CN102286504B - Lycopene cyclase gene in sphingomonas sp. and use thereof - Google Patents
Lycopene cyclase gene in sphingomonas sp. and use thereof Download PDFInfo
- Publication number
- CN102286504B CN102286504B CN 201110184745 CN201110184745A CN102286504B CN 102286504 B CN102286504 B CN 102286504B CN 201110184745 CN201110184745 CN 201110184745 CN 201110184745 A CN201110184745 A CN 201110184745A CN 102286504 B CN102286504 B CN 102286504B
- Authority
- CN
- China
- Prior art keywords
- gene
- sphingomonas
- sphingomonas paucimobilis
- crty
- lycopene cyclase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108060004506 lycopene beta-cyclase Proteins 0.000 title claims abstract description 19
- 108060004507 lycopene cyclase Proteins 0.000 title claims abstract description 19
- 241001135759 Sphingomonas sp. Species 0.000 title claims abstract description 9
- 238000003209 gene knockout Methods 0.000 claims abstract description 22
- 238000000855 fermentation Methods 0.000 claims abstract description 11
- 230000004151 fermentation Effects 0.000 claims abstract description 11
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 241000736110 Sphingomonas paucimobilis Species 0.000 claims description 48
- 230000002950 deficient Effects 0.000 claims description 11
- 239000012634 fragment Substances 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- 101150085103 crtY gene Proteins 0.000 abstract description 30
- 238000000034 method Methods 0.000 abstract description 18
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 8
- 235000021466 carotenoid Nutrition 0.000 abstract description 6
- 150000001747 carotenoids Chemical class 0.000 abstract description 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract description 5
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract description 4
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract description 4
- 235000012661 lycopene Nutrition 0.000 abstract description 4
- 229960004999 lycopene Drugs 0.000 abstract description 4
- 239000001751 lycopene Substances 0.000 abstract description 4
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000012239 gene modification Methods 0.000 abstract description 2
- 230000005017 genetic modification Effects 0.000 abstract description 2
- 235000013617 genetically modified food Nutrition 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000012269 metabolic engineering Methods 0.000 abstract description 2
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 24
- 239000013612 plasmid Substances 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 13
- 238000012216 screening Methods 0.000 description 13
- 230000006801 homologous recombination Effects 0.000 description 9
- 238000002744 homologous recombination Methods 0.000 description 9
- 238000011144 upstream manufacturing Methods 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- 101150025220 sacB gene Proteins 0.000 description 6
- 229920002148 Gellan gum Polymers 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000000216 gellan gum Substances 0.000 description 5
- 235000010492 gellan gum Nutrition 0.000 description 5
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010079 rubber tapping Methods 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- HGVJFBSSLICXEM-UHNVWZDZSA-N (2s,3r)-2-methylbutane-1,2,3,4-tetrol Chemical compound OC[C@@](O)(C)[C@H](O)CO HGVJFBSSLICXEM-UHNVWZDZSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- OINNEUNVOZHBOX-QIRCYJPOSA-K 2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-) Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP([O-])(=O)OP([O-])([O-])=O OINNEUNVOZHBOX-QIRCYJPOSA-K 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HGVJFBSSLICXEM-UHFFFAOYSA-N L-2-methyl-erythritol Natural products OCC(O)(C)C(O)CO HGVJFBSSLICXEM-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101100309436 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) ftf gene Proteins 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- -1 isoprenoid compounds Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101100171666 Arabidopsis thaliana SFP2 gene Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 101710095468 Cyclase Proteins 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229920002444 Exopolysaccharide Polymers 0.000 description 1
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 1
- 108010066605 Geranylgeranyl-Diphosphate Geranylgeranyltransferase Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 108010065958 Isopentenyl-diphosphate Delta-isomerase Proteins 0.000 description 1
- 102100027665 Isopentenyl-diphosphate Delta-isomerase 1 Human genes 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 101150003216 SFP1 gene Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100422767 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) SUL1 gene Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 125000002686 geranylgeranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 108010005131 levanase Proteins 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Natural products CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000007218 ym medium Substances 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides the DNA sequence of a lycopene cyclase gene (crtY) in sphingomonas sp., a recombinant strain lacking lycopene cyclase and use thereof. The nucleotide sequence of the crtY gene is represented by SEQ ID NO.1. The DNA sequence of the lycopene cyclase gene (crtY) in sphingomonas sp., which is provided by the invention, lays a foundation for the genetic modification of a sphingomonas sp. carotenoid biological synthesis means. In addition, compared with a wild strain, the sphingomonas sp. recombinant strain lacking the lycopene cyclase gene, which is constructed by a gene knockout method, has the advantages that: the gellengum yield is basically unchanged; and lycopene can be produced in the production of gellengum by fermentation. And the strain can be used for further gene knockout or metabolic engineering modification.
Description
(1) technical field
The present invention relates to sphingomonas paucimobilis lycopene cyclase gene (crtY), lack restructuring sphingomonas paucimobilis and the application thereof of this gene.
(2) background technology
Gelling gum is by β-1,3-D-glucose, β-Isosorbide-5-Nitrae-D-Glucose aldehydic acid, β-1, and 3-D-glucose, α-Isosorbide-5-Nitrae-L-rhamnosyl connect the Microbial exopolysaccharides that polymerization consists of.Compared with similar products, it has the lot of superiority energy, and is few such as consumption; Zero pour, fusing point etc. are adjustable; Acidproof, alkaline-resisting, thermostability is high; Good water-soluble, be flavor property, moisture retention, film-forming properties, slow-releasing etc.In recent years, gelling gum is used as New-type emulsifier, suspension agent, thickening material, stablizer, gelifying agent, sustained release dosage, film forming material etc. and is applied to the industrial circles such as food, medicine, chemical industry increasingly extensively.In addition, gelling gum can with the composite use of other foodstuff glues, make food can obtain best sense organ, matter structure and stability requirement.Gelling gum has a extensive future, and applies yet its higher production cost has limited.
Gelling gum is by the sphingomonas paucimobilis fermentative production.Sphingomonas paucimobilis is a kind of Gram-negative, and aerobic bacillus and end are given birth to flagellum, produces yellow carotenoid when gelling gum is produced in its fermentation.The biosynthetic pathway of carotenoid has been widely studied and has obtained huge progress, and a large amount of key genes obtain the clone.All carotenoid is all synthetic by isoprenoid compounds or terpenoid approach.IPP (isopentenylpyrophosphate) is the precursor substance of this route of synthesis.In most of bacterium, IPP is synthetic through MEP (2-C-methyl D-erythritol) approach by pyruvic acid and glyceraldehyde 3-phosphate.IPP generates DMAPP (dimethyl propylene thiazolinyl bisphosphate) under the effect of IPP isomerase, and then generates GGPP (geranyl geranyl tetra-sodium) with 3 IPP condensations.Two molecule GGPP form first colourless carotenoid-phytoene under the effect of phytoene synthetase, route of synthesis forms a lot of branches afterwards.In most bacterium, phytoene is forming red Lyeopene after through 4 continuous dehydrogenation steps under the effect of phytoene dehydrogenase.Lyeopene is again through forming various types of carotene under the effect of a series of different enzymes such as cyclase, hydroxylase, ketonize enzyme.
Lyeopene is a kind of of carotenoid, by 11 conjugation and 2 straight chain type hydrocarbon polymers that non-conjugated carbon-to-carbon double bond forms.Lyeopene has very strong oxidation-resistance, and efficiently singlet-oxygen quenching is removed interior free yl, has the anticancer effect that presses down cancer, preventing cardiovascular disease, enhancing human immune system and delay senility.As functional natural colorants, Lyeopene is increasingly extensive in the application of the aspects such as food, healthcare products, makeup and medicine, and demand is increasing, and market outlook are wide.
Thereby sphingomonas paucimobilis lycopene cyclase gene order is not yet arranged and utilize gene Knockout to knock out the report of sphingomonas paucimobilis lycopene cyclase gene gellan gum fermentation coproduction Lyeopene at present.
(3) summary of the invention
The purpose of this invention is to provide the dna sequence dna of lycopene cyclase gene of sphingomonas paucimobilis and recombinant bacterial strain and the application thereof of this enzyme disappearance.
The technical solution used in the present invention is:
The lycopene cyclase gene (crtY) of sphingomonas paucimobilis (Sphingomonas sp.), nucleotide sequence is shown in SEQ ID NO.1.This sequence length is 1158bp, the protein that is comprised of 385 amino acid of encoding.
The invention still further relates to a kind of restructuring sphingomonas paucimobilis of crtY genetically deficient, remove the crtY gene order shown in the SEQ ID NO.1 by sphingomonas paucimobilis through gene knockout and obtain.
Gene knockout is this area routine techniques, and in the known gene order situation that is knocked, those of ordinary skills can select ordinary method to carry out the gene knockout operation according to general knowledge.Specifically can be performed as follows:
1, take the sphingomonas paucimobilis genome as template, utilize the upstream and downstream segment of PCR method amplification crtY gene, respectively the upstream and downstream segment is inserted conventional knockout carrier pLO3 and made up crtY gene knockout carrier pLO3-△ Y;
2, crtY gene knockout carrier pLO3-△ Y is imported in the sphingomonas paucimobilis by three close method of joining;
3, for the first time wholely during homologous recombination knock out homologous site, the tetracyclin resistance screening that plasmid inserts in the genome and obtain positive recombinant, and with PCR method amplification sacB gene identification.The homologous recombination that screening is obtained exchanges for the first time positive recombinant and inoculates and go down to posterity in the preculture substratum three times, then is coated on the screening flat board that contains 8% sucrose with screening homologous recombination permutoid for the second time.The homologous recombination body second time that screening obtains is xeroxed and is further identified to the resistant panel that contains tsiklomitsin and with PCR method, thereby obtains the sphingomonas paucimobilis of crtY genetically deficient.
Among the present invention, described gene knockout can be undertaken by the nucleotide fragment shown in the SEQ ID NO.2.Specific as follows: as respectively SEQ ID NO.2 middle and upper reaches (SEQ ID NO.2 the 396th~773 bit base) downstreams (SEQ ID NO.2 the 1542nd~2018 bit base) segment to be inserted knockout carrier pLO3 and made up crtY gene knockout carrier pLO3-△ Y; Then crtY gene knockout carrier pLO3-△ Y is imported in the sphingomonas paucimobilis by three close method of joining, obtain the restructuring sphingomonas paucimobilis of crtY genetically deficient through screening.The dna sequence dna of SEQ ID NO.2 comprises altogether 2018bp of crtY gene, obtain by the following method: according to the partial sequence of sphingomonas paucimobilis ATCC31461crtY (the NCBI accession number: HQ202920) design gene-specific primer, and then by the SiteFinding-PCR technology obtain to comprise the crtY gene complete sequence and with the NCBI accession number be that the sequence assembly of HQ202920 obtains the required part flanking sequence of gene knockout.
The invention still further relates to described restructuring sphingomonas paucimobilis and prepare application in gelling gum and the Lyeopene at microbial fermentation.
Beneficial effect of the present invention is mainly reflected in: the dna sequence dna of sphingomonas paucimobilis lycopene cyclase gene provided by the invention (crtY) is that the sphingomonas paucimobilis Carotenoid biosynthetic pathway carries out genetic modification and lays the foundation.In addition, the present invention compares with wild type strain by the sphingomonas paucimobilis recombinant bacterial strain of the lycopene cyclase disappearance of the method structure of gene knockout, the substantially constant and product Lyeopene of gelling gum output, thereby can gellan gum fermentation coproduction Lyeopene, simultaneously, this bacterial strain can also be applied to further metabolic engineering.
(4) description of drawings
Fig. 1 is the structural representation of pLO3 plasmid;
Fig. 2 is the electrophorogram that the PCR method is identified the crtY gene knockout: 1 take the sphingomonas paucimobilis genome of the crY genetically deficient that makes up as template (1107bp), and 2 compare (1869bp) take wild-type sphingomonas paucimobilis genome as template.
(5) embodiment
The present invention is described further below in conjunction with specific embodiment, but protection scope of the present invention is not limited in this:
Embodiment 1: the acquisition of sphingomonas paucimobilis crtY gene DNA sequence
According to the partial sequence of sphingomonas paucimobilis ATCC 31461 crtY (the NCBI accession number: HQ202920) design upstream gene Auele Specific Primer, by the SiteFinding-PCR technology obtain to comprise the crtY gene complete sequence and with the NCBI accession number be that the sequence assembly of HQ202920 obtains the required part flanking sequence of gene knockout.Used upstream gene Auele Specific Primer, SiteFinder, SFP primer sequence are as follows:
The upstream sequence Auele Specific Primer:
UP1:5′-GCTGTAATAGGTGTCCTCGACGA-3′
UP2:5′-TGAACGGCAGGCAATAGACGAAG-3′
SiteFinder:
SiteFl:
5′-CACGACACGCTACTCAACACACCACCACGCACAGCGTCCTCAANNNNNNCATGG-3′
SiteF2:
5′-CACGACACGCTACTCAACACACCACCACGCACAGCGTCCTCAANNNNNNCATGC-3′
SiteF3:
5′-CACGACACGCTACTCAACACACCACCACGCACAGCGTCCTCAANNNNNNGCCT-3′
SiteF4:
5′-CACGACACGCTACTCAACACACCACCACGCACAGCGTCCTCAANNNNNNGCCACG-3′
The SFP primer:
SFP1:5′-CACGACACGCTACTCAACAC-3′
SFP2:5′-ACTCAACACACCACCACGCACAGC-3′
Extraction genomic dna from sphingomonas paucimobilis Sphingomonas paucimobilis ATCC 31461 (buying from ATCC) (using AxyPrep bacterial genomes DNA to prepare in a small amount test kit) is connected on pMD19-T (Takara) carrier after reclaiming (use AxyPrep dna gel reclaims test kit) purifying as the target dna segment rubber tapping that pcr template utilizes the amplification of SiteFing-PCR technology to obtain, transform intestinal bacteria Top10 competent cell, picking ammonia benzyl resistance clone, bacterium colony PCR identifies the PCR fragment of whether inserting recovery among the pMD19-T.To positive colony order-checking (Invitrogen company mensuration), and make BLAST and analyze, the upstream target dna segment that discovery obtains comprises initiator codon, be to be used in the sequence of HQ202920 knocking out obtaining a segment length behind the sequence assembly of crtY gene and being the dna sequence dna of 2018bp with above-mentioned sequence and NCBI accession number, shown in SEQ ID No.2, the crtY gene that wherein comprises (SEQ ID No.1) total length is 1158bp (SEQ ID No.2 the 621st bit base~the 1778th bit base).
Embodiment 2: the structure of the sphingomonas paucimobilis recombinant bacterial strain of lycopene cyclase disappearance
1, the structure of gene knockout carrier pLO3-△ Y
According to the dna sequence dna design primer that obtains.From sphingomonas paucimobilis Sphingonmonas paucimobilis ATCC 31461 (ATCC purchase), extract genomic dna (using AxyPrep bacterial genomes DNA to prepare in a small amount test kit) as pcr template.Y1, Y2 are primer Taq enzyme (Takara) amplification upstream homologous sequence, and the PCR response procedures is that 95 ℃ of denaturation 5min enter working cycle; 94 ℃ of sex change 30sec, 62 ℃ of annealing 30sec, 72 ℃ are extended 30sec, and 30 circulations are extended 10min with 72 ℃ at last.Y3, Y4 are primer Taq enzyme (Takara) amplification downstream homologous sequence, and the PCR response procedures is: 95 ℃ of denaturation 5min enter working cycle; 94 ℃ of sex change 30sec, 63 ℃ of annealing 30sec, 72 ℃ are extended 40s, and 30 circulations are extended 10min with 72 ℃ at last.Above-mentioned primer sequence is as follows:
Y1:5 '-AT
GAGCTCCAACCTGTTCAACACCAC-3 ' underscore is the SacI restriction enzyme site
Y2:5 '-GCG
TCTAGAGAACGACCAGAGGTGATT-3 ' underscore is the XbaI enzyme cutting site
Y3:5 '-CG
TCTAGATATTCCCGTGGGCTCTGG-3 ' underscore is the XbaI enzyme cutting site
Y4:5 '-AC
GTTTAAACTCAGCGTCACATCTTCCG-3 ' underscore is the PmeI restriction enzyme site
Then PCR product 1% agarose gel electrophoresis reclaims the test kit rubber tapping with the AxyPrep dna gel and reclaims.
The upstream segment (SEQ ID NO.2 the 396th~773 bit base) that reclaims, conventional gene knockout plasmid pLO3 (from Oliver doctor Lenz of Germany) are after 37 ℃ of double digestions of SacI, XbaI spend the night, segment PCR cleaning in upstream reclaims (using AxyPrep PCR cleaning to reclaim test kit), 4 ℃ of connections of T4DNA ligase were spent the night after plasmid 1% agarose gel electrophoresis and rubber tapping were reclaimed, and transformed intestinal bacteria S17-1 competent cell.Dull and stereotyped (adding the tsiklomitsin of the 25 μ g/ml) screening positive clone of LB.Screening gained positive colony bacterium colony PCR checking is extracted the further enzyme of plasmid and is cut checking and order-checking.Clone by checking extracts plasmid, called after pLO3-Y1.
PLO3-Y1 (SEQ ID NO.2 the 1542nd~2018 bit base) similarly clones and verifies after XbaI, a PmeI37 ℃ double digestion spends the night, the gene knockout carrier called after pLO3-△ Y that builds.
2, gene knockout carrier pLO3-△ Y transforms
Gene knockout carrier pLO3-△ Y adopts three close method of joining to import among sphingomonas paucimobilis ATCC 31461 and the DSM 6314.Three close engaging processes need three kinds of bacteriums: the intestinal bacteria donor bacterium S17-1/pLO3-△ Y (pressing preceding method obtains) that 1. contains recombinant plasmid pLO3-△ Y;
2. the intestinal bacteria " assistance " that contain conventional helper plasmid pRK2013 are bacterium HB101/pRK2013 (from Institute of Genetics, Academia Sinica) (helper); 3. sphingomonas paucimobilis ATCC 31461 or DSM 6314 (from the DSM of DSMZ) (recipient bacterium).When three kinds of bacterium mix, assist plasmid pRK2013 to move about and enter in the intestinal bacteria, provide and move about (mob) and shift (tra) function, the recombinant plasmid pLO3-△ Y of donor transfer is entered in the sphingomonas paucimobilis.Transfer vector plasmid need to be with a specific starting point (oirT) that shifts in this system, and it works driven transfer so that assist the tra of plasmid and mob gene pairs.The pLO3 plasmid is tetracyclin resistance, contains the reverse selection markers sacB gene of sucrose, pBR322_origin replication orgin and oriT_RP4 and shifts starting point.This plasmid can copy in intestinal bacteria, but can not in sphingomonas paucimobilis, copy, so the pLO3 plasmid can only be integrated into karyomit(e) on the same group through homology when entering sphingomonas paucimobilis, copy together with karyomit(e), and can not be present in outside the karyomit(e) with free form.Utilize these characteristics of pLO3 plasmid, thereby the homology segment of wanting to knock out the gene both sides is cloned into the integration site of pLO3 plasmid location pLO3 plasmid.The principle of utilizing the homology dna segment to recombinate makes up the genetically deficient bacterial strain.It is as described below that three parents engage concrete grammar:
Sphingomonas paucimobilis is 30 ℃, 200rpm overnight incubation in the preculture substratum.Cultivate 8h with 30 ℃ of 10% inoculum size switching preculture substratum, 200rpm.S17-1/pLO3-△ Y, HB101/pRK2013 be 37 ℃ of overnight incubation in adding corresponding antibiotic LB liquid nutrient medium (microbiotic addition: tsiklomitsin 25 μ g/ml, kantlex 50 μ g/ml).Get S17-1/pLO3-△ Y, the centrifugal collection thalline of each 2ml of HB101/pRK2013 bacterium liquid (3000rpm, 5min); Get sphingomonas paucimobilis 5ml, the centrifugal 5min of 6000rpm abandons supernatant, uses respectively the aseptic deionized water washed twice, and is centrifugal.Above-mentioned 3 kinds of bacterium are merged, with behind the resuspended mixing of 5ml aseptic deionized water with the filter membrane suction filtration of 0.45 μ m aperture diameter 5cm.The filter membrane thalline is attached in the LB flat board up, and 37 ℃ leave standstill and with the 5ml aseptic deionized water thalline on the filter membrane washed after cultivating 7h, and gradient dilution coating to the suitable concn contains the YM flat board of 25 μ g/ml Streptomycin sulphates, 5 μ g/ml tsiklomitsins.Used substratum is composed as follows:
The preculture substratum: yeast extract paste 0.2%, extractum carnis 0.3%, peptone 0.5%, NaCl 0.1%, and glucose 0.5%, solvent are distilled water, pH7.2;
The YM solid medium: yeast powder 0.3%, malt meal 0.3%, peptone 0.5%, glucose 1%, agar powder 1.5%, solvent are distilled water, pH7.2;
Annotate: substratum concentration all refers to the quality concentration of volume percent among the present invention, contains this material of 1g in certain concentration of component 1% expression 100mL substratum.
3, the screening of the sphingomonas paucimobilis recombinant bacterial strain of crtY genetically deficient
For the first time during homologous recombination, plasmid integration enters genome.The clone that the tetracyclin resistance screening obtains extracts genome, sacB primer PCR amplification sacB gene identification positive recombinant.The PCR response procedures is: 95 ℃ of denaturation 5min enter working cycle; 94 ℃ of sex change 30sec, 50 ℃ of annealing 30sec, 72 ℃ are extended 90sec, and 30 circulations are extended 10min with 72 ℃ at last.The PCR product is the positive recon of 1151bp segment.
Above-mentioned checking primer sequence is as follows:
sacBsense:5′-CGAACCAAAAGCCATATAAG-3′
sacBanti:5′-AGCGAAGTGTGAGTAAGTAA-3′
The homologous recombination plasmid breaks away from genomic dna for the second time, produces two kinds of switch types: deletion mutantion bacterial strain (redness) and wild type strain (yellow).The positive colony that the first time, the homologous recombination screening obtained is inoculated and is gone down to posterity in the preculture substratum three times, and it is dull and stereotyped upper to screen for the second time homologous recombination permutoid then to be coated on the screening of 8% sucrose.Because it is Polylevulosan that the sucrose levanase of sacB genes encoding can make sucrose inversion.Polylevulosan is toxic to cell, only loses the sacB gene and could grow in the presence of high concentration sucrose.Therefore can utilize high concentration sucrose oppositely to screen and obtain removing wild type strain or the deletion mutantion bacterial strain that integration knocks out plasmid.The permutoid second time that screening obtains is xeroxed the YM plate culture medium that contains 5 μ g/ml tsiklomitsins, exchanges resistance marker for the second time with further affirmation and loses.
Selecting at random for the second time, the homologous recombination phenotype is that primer PrimeSTAR HS DNA Polymerase enzyme (Takara) PCR confirms further whether the crtY gene knocks out for red permutoid with Y5, Y6.The PCR response procedures is: 95 ℃ of denaturation 5min enter working cycle; 98 ℃ of sex change 10sec, 59 ℃ of annealing 15sec, 72 ℃ are extended 2min, 30 circulations.Do simultaneously the PCR contrast take the wild type strain genome as template, electrophoresis result as shown in Figure 2, PCR product take the wild type strain genome as template is 1869bp, and the PCR product take the sphingomonas paucimobilis genome of crtY genetically deficient as template is as 1107bp.Experiment showed, that through this phenotype is the red crtY gene deletion mutants that is really.
Y5:5′-CCAAGATCACCCAGGACC-3′
Y6:5′-CAGCGTCACATCTTCCGA-3′
The sphingomonas paucimobilis bacterial strain of embodiment 3:crtY genetically deficient produces the mensuration of glue ability
1, sphingomonas paucimobilis (the △ Y1~△ Y7 of wild type strain (Sphingomonas paucimobilis ATCC 31461) and crtY genetically deficient, wherein △ Y1~△ Y4 derives from sphingomonas paucimobilis ATCC 31461, △ Y5~△ Y7 then derives from sphingomonas paucimobilis DSM 6314) connect on the YM medium slant, cultivate 72h for 30 ℃;
2, first order seed is cultivated: with inclined-plane seed access 50ml first order seed substratum (being contained in the 250ml triangular flask), in 30 ℃, 200rpm shaking culture 24h is primary seed solution respectively;
3, secondary seed is cultivated: with the inoculum size access 100ml secondary seed medium (be contained in 500mL triangular flask) of primary seed solution with 5% volume ratio, in 30 ℃, 200rpm shaking culture 12h is secondary seed solution respectively;
4, fermentation: the inoculum size of secondary seed solution with 5% volume ratio accessed in the 100mL level fermention medium (being contained in the 500mL triangular flask), in 30 ℃, 200rpm oscillation and fermentation 48h;
5, measure respectively viscosity and the rate of gum output of the fermented liquid of the sphingomonas paucimobilis (△ Y1~△ Y7) that contrasts (wild type strain) and crtY genetically deficient, result such as table 1:
Table 1, wild strain and mutant strain fermentation 48h rate of gum output, viscosity
Compared with the control, △ Y bacterial strain rate of gum output and viscosity significantly do not change, and rate of gum output is in same level with respect to control strain, therefore can select △ Y as producing bacterial strain, and gelling gum output can not reduce, and can gellan gum fermentation coproduction Lyeopene.Used medium consists of:
First order seed substratum: yeast extract paste 0.20%; Extractum carnis 0.30%; Peptone 0.50%; Repone K 0.10%, solvent are distilled water, pH7.2;
Secondary seed medium: glucose 1.50%; Yeast extract paste .0.50%; Peptone 0.50%; Potassium primary phosphate 0.06%; Dipotassium hydrogen phosphate 0.06%; Sal epsom 0.06%, solvent are distilled water, pH7.2;
Fermention medium: glucose 3.00%; Yeast extract paste 0.05%; Peptone 0.30%; Potassium primary phosphate 0.06%; Dipotassium hydrogen phosphate 0.10%; Sal epsom 0.06%; Solvent is distilled water, pH7.2.Embodiment 4: the preparation technology of lycopene cyclase deletion mycopremna high acyl gellan gum and the extraction process of Lyeopene
1, fermentation liquor pretreatment: fermented liquid 100L, the HCl accent pH6.0 with 10% (v/v) is warming up to 60 ℃, insulation 1h;
2, albumen Impurity removal: when being cooled to 40 ℃, transfer pH7.0 with 10% (w/v) NaOH, add the N,O-Diacetylmuramidase (200,000 U/g, Pang Bo is biological) of 50g and the Sumizyme MP (20,000 U/g, Pang Bo is biological) of 100g, insulation 2h;
3, gelling gum flocculation sediment separates and Lyeopene extracts: add 40 ℃ of lucifuges of 50L ethanol acetone soln (v/v=2: 1~1: 2, preferred 1: 1) in the fermented liquid after processing through pre-treatment and albumen impurity elimination and stir and extract 2h.Filter press after extracting 4 times is collected filtrate, adds an amount of BHT.
4, dry, the pulverizing of gelling gum: pulverize behind 90 ℃ of dry 2h of press filtration gained fiber material, make the high acyl gellan gum finished product, be off-white powder, nitrogen content is 0.05~0.30%.
5, filtrate with Rotary Evaporators 35 ℃ of vacuum concentration to 500mL, the absorption with macroporous adsorbent resin Lyeopene, with acetone to the macroporous resin that adsorbed Lyeopene wash-out at normal temperatures.
6, the elutriant that obtains is concentrated into certain volume, it is dry to put into 45 ℃ of vacuum drying ovens, obtains lycopene crystal.
7, the lycopene crystal that obtains is dissolved in proper amount of acetone, filtration and recrystallization obtains the 0.85g lycopene crystal.It is 97% that high performance liquid chromatography detects Lyeopene purity.
SEQUENCE LISTING
<110〉Zhejiang University
<120〉lycopene cyclase gene and the application thereof of sphingomonas paucimobilis
<130>
<160> 14
<170> PatentIn version 3.4
<210> 1
<211> 1158
<212> DNA
<213> Sphingomonas sp.
<400> 1
atgccttcaa ccatcagttg tgacgtcgcc attgtaggcg gcggccttgc cggcgggctt 60
atcgcgctgg caatccggaa gaagaaaccc gattgcaccg tccggctcat cgaaggctcg 120
gcgcggatcg gcggcaatca cctctggtcg ttcttcgccg acgacgtggc gcccgagcat 180
cgctggctgg ccgccccgct gatcggccat ggctggaacg gctatgacgt cgccttcccc 240
ggccatttcc gtaccctgcc cgcccgctat tattcggtcg aatccgatca tttcgatcgc 300
gtcgtgcgcg gggcgctggg cgagaagagt ctgctgctcg aacgcgaggc ggcggacatc 360
actcccaccg ccgtcgcgct cgcggacggc gacctggtcg aggccgaggg cgtgatcgac 420
tgccgcgggg tgagcgatac cagtgcgctc cagcttggct ggcagaaatt ccacggcgcc 480
gaactggcgc tcagcgacct gcacgacgtc acccgcccga tcatcatgga cggcacggtg 540
ccgcagatcg acggctatcg cttcgtctat tgcctgccgt tcagcccgac gcggatgttc 600
gtcgaggaca cctattacag cgacacgccg gcgctcgaca tcctcgccac cggcgaccgg 660
atcgaagcct atgccgatgc cgcgggctgg aaggtcgacc gcgtgctgcg cgaggaagtg 720
ggcagcctgc ccgtcgcgat gggcggcgac catgccgcct attgggcggc cggcgggcgc 780
ggcatcgcca aggccgggat gaaggccggg ctgttccacc cgatgaccgg ctattccttc 840
cccgatgcga tccgcaccgc cgcgctgatc gccgacgcgc gcgactattc gggcgaggcg 900
ctgcaccaaa tgctgtatgg ctattcccgt gggctctggc gcaagcgcgg cttctatcgc 960
atgctcgccg cgatgctgtt caaggcggcc gaacccgagg agcgctatcg cgtgctggaa 1020
cgtttctatc gtctggatgc aggtctgatc cagcgcttct atgccggcca gtcgaccttc 1080
ggcgatcgcg tgcgggtgct ttcgggcaag ccgccggtgc cggtggggcg cgccctttcc 1140
gcgatctgga gccgctga 1158
<210> 2
<211> 2018
<212> DNA
<213> Sphingomonas sp.
<400> 2
gccttccgcg cgacggccga ggaccacaat gtcctcaacg gatcggccaa ccagaccatc 60
cgcagctatc gcgccaccgg tgtcgaaatg gagggcagct atcgtcgcgg catcttcagc 120
atcaccgccg gtgccaccta caccaccgcc aagatcaccc aggaccggct ggattccacg 180
ctgaccggca aggaaccccg ccaccagccg gcctggacgc tggaggcgac gccgcagatc 240
gagctgcgcc gggtaacgct gggcgccaac atcgtgacga tcaccagcag ctatgcgcaa 300
gacagcaacc tgctcaagat gccgggcttc accaccgtcg cggcgttcgt gatcgtcaag 360
ccggtggatc gcgtgcagct gatgctcaac gcgaccaacc tgttcaacac caccggcttc 420
ttcgacatca accaaagcga ggtacccgcc aacggcatcg gctgggcccg cgcgatcaac 480
gggcggacgg tatccgcctc ggccaagctg agcttctgat ccgcgacatg gcgggcgccg 540
gtcacgcgcc cgccatcgct tcggcgctcg ggctcaatgg aggggtttcc acgccccggg 600
cgttgggcta ggcggcagtc atgccttcaa ccatcagttg tgacgtcgcc attgtaggcg 660
gcggccttgc cggcgggctt atcgcgctgg caatccggaa gaagaaaccc gattgcaccg 720
tccggctcat cgaaggctcg gcgcggatcg gcggcaatca cctctggtcg ttcttcgccg 780
acgacgtggc gcccgagcat cgctggctgg ccgccccgct gatcggccat ggctggaacg 840
gctatgacgt cgccttcccc ggccatttcc gtaccctgcc cgcccgctat tattcggtcg 900
aatccgatca tttcgatcgc gtcgtgcgcg gggcgctggg cgagaagagt ctgctgctcg 960
aacgcgaggc ggcggacatc actcccaccg ccgtcgcgct cgcggacggc gacctggtcg 1020
aggccgaggg cgtgatcgac tgccgcgggg tgagcgatac cagtgcgctc cagcttggct 1080
ggcagaaatt ccacggcgcc gaactggcgc tcagcgacct gcacgacgtc acccgcccga 1140
tcatcatgga cggcacggtg ccgcagatcg acggctatcg cttcgtctat tgcctgccgt 1200
tcagcccgac gcggatgttc gtcgaggaca cctattacag cgacacgccg gcgctcgaca 1260
tcctcgccac cggcgaccgg atcgaagcct atgccgatgc cgcgggctgg aaggtcgacc 1320
gcgtgctgcg cgaggaagtg ggcagcctgc ccgtcgcgat gggcggcgac catgccgcct 1380
attgggcggc cggcgggcgc ggcatcgcca aggccgggat gaaggccggg ctgttccacc 1440
cgatgaccgg ctattccttc cccgatgcga tccgcaccgc cgcgctgatc gccgacgcgc 1500
gcgactattc gggcgaggcg ctgcaccaaa tgctgtatgg ctattcccgt gggctctggc 1560
gcaagcgcgg cttctatcgc atgctcgccg cgatgctgtt caaggcggcc gaacccgagg 1620
agcgctatcg cgtgctggaa cgtttctatc gtctggatgc aggtctgatc cagcgcttct 1680
atgccggcca gtcgaccttc ggcgatcgcg tgcgggtgct ttcgggcaag ccgccggtgc 1740
cggtggggcg cgccctttcc gcgatctgga gccgctgatg cgccgcgcag tcgtgatcgg 1800
cgccggtttc ggcggtctcg ctctcgccat ccgcctgcag tccgcggggg tcgacaccac 1860
cgtgatcgag gcccgggaca agcccggcgg ccgcgcctat tattgggagc gcgacggctt 1920
caccttcgac ggcggcccga cggtgatcac cgatccggac gcgctgaagg agctgtggcg 1980
cctctcgggc cacgacatct cggaagatgt gacgctga 2018
<210> 3
<211> 23
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<400> 3
gctgtaatag gtgtcctcga cga 23
<210> 4
<211> 23
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<400> 4
tgaacggcag gcaatagacg aag 23
<210> 5
<211> 54
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<220>
<221> misc_feature
<222> (44)..(49)
<223> n is a, c, g, or t
<400> 5
cacgacacgc tactcaacac accaccacgc acagcgtcct caannnnnnc atgg 54
<210> 6
<211> 54
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<220>
<221> misc_feature
<222> (44)..(49)
<223> n is a, c, g, or t
<400> 6
cacgacacgc tactcaacac accaccacgc acagcgtcct caannnnnnc atgc 54
<210> 7
<211> 53
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<220>
<221> misc_feature
<222> (44)..(49)
<223> n is a, c, g, or t
<400> 7
cacgacacgc tactcaacac accaccacgc acagcgtcct caannnnnng cct 53
<210> 8
<211> 55
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<220>
<221> misc_feature
<222> (44)..(49)
<223> n is a, c, g, or t
<400> 8
cacgacacgc tactcaacac accaccacgc acagcgtcct caannnnnng ccacg 55
<210> 9
<211> 20
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<400> 9
cacgacacgc tactcaacac 20
<210> 10
<211> 24
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<400> 10
actcaacaca ccaccacgca cagc 24
<210> 11
<211> 26
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<400> 11
atgagctcca acctgttcaa caccac 26
<210> 12
<211> 27
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<400> 12
gcgtctagag aacgaccaga ggtgatt 27
<210> 13
<211> 26
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<400> 13
cgtctagata ttcccgtggg ctctgg 26
<210> 14
<211> 28
<212> DNA
<213> Unknown
<220>
<223〉artificial sequence
<400> 14
acgtttaaac tcagcgtcac atcttccg 28
Claims (3)
- Sphingomonas paucimobilis ( Sphingomonas sp.) the lycopene cyclase gene, nucleotide sequence is shown in SEQ ID NO.1.
- 2. the restructuring sphingomonas paucimobilis of a lycopene cyclase genetically deficient, remove the lycopene cyclase gene order shown in the SEQ ID NO.1 by sphingomonas paucimobilis ATCC 31461 or DSM 6314 through gene knockout and obtain, described gene knockout is undertaken by the nucleotide fragment shown in the SEQ ID NO.2.
- 3. restructuring sphingomonas paucimobilis as claimed in claim 2 prepares application in gelling gum and the Lyeopene at microbial fermentation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110184745 CN102286504B (en) | 2011-07-01 | 2011-07-01 | Lycopene cyclase gene in sphingomonas sp. and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110184745 CN102286504B (en) | 2011-07-01 | 2011-07-01 | Lycopene cyclase gene in sphingomonas sp. and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102286504A CN102286504A (en) | 2011-12-21 |
CN102286504B true CN102286504B (en) | 2013-04-10 |
Family
ID=45333261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110184745 Expired - Fee Related CN102286504B (en) | 2011-07-01 | 2011-07-01 | Lycopene cyclase gene in sphingomonas sp. and use thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102286504B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104152473B (en) * | 2014-08-18 | 2019-07-12 | 中国烟草总公司郑州烟草研究院 | Tobacco Carotenoid isomerase gene and its application |
CN104152474B (en) * | 2014-08-18 | 2019-06-28 | 中国烟草总公司郑州烟草研究院 | Tobacco Tomato red pigment β cyclase gene and its application |
CN104152475B (en) * | 2014-08-18 | 2019-08-16 | 中国烟草总公司郑州烟草研究院 | Tobacco ε-lycopene cyclase gene and its application |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1380415A (en) * | 2001-04-06 | 2002-11-20 | 上海永业农科生物工程有限公司 | Synthesis of related gene for producing carotenoid in transgenic plant |
CN101838667B (en) * | 2010-01-13 | 2013-05-29 | 新疆大学 | Method for producing lycopene by fermentation of blakeslea trispora |
-
2011
- 2011-07-01 CN CN 201110184745 patent/CN102286504B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102286504A (en) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101979587B (en) | Phytoene desaturase gene of sphingomonas sp. and application thereof | |
CN103820335B (en) | Mortierella alpina, M. alpina genetic engineering strain of overexpression omega 3 desaturase gene and construction method of strain | |
WO2020244527A1 (en) | Recombinant bacillus subtilis capable of increasing yield of menaquinone-7 and use thereof | |
US7217537B2 (en) | Method to increase carotenoid production in a microbial host cell by down-regulating glycogen synthase | |
CN104974944B (en) | Schizochytrium limacinum genetic engineering strain for producing DHA (docosahexaenoic acid), and construction method and application thereof | |
CN110157654B (en) | Bacillus natto recombinant strain and construction method and application thereof | |
CN113652440B (en) | 3-ketoacyl coenzyme A thiolase gene RKACAA1-2 and application thereof | |
CN102286504B (en) | Lycopene cyclase gene in sphingomonas sp. and use thereof | |
CN107475311A (en) | For producing method and the microorganism of lipid | |
CN103937734A (en) | Genetically-engineered bacterium realizing high production of hyaluronic acid and application thereof | |
CN107574173A (en) | A kind of recombinant plasmid and its method for building High-productive Monascus Pigment Strain | |
CN105039374B (en) | A kind of starch induction type recombined bacillus subtilis and preparation method and application | |
CN104017738A (en) | High-yield engineering strain kmust-SQS for ganoderic acid | |
JP5719437B2 (en) | Genetically modified Streptomyces strain and method for producing isovaleryl spiramycin I | |
CN102286495B (en) | CrtZ gene and crtG gene in sphingomonas sp. and use thereof | |
CN105238797B (en) | Mutant gene of gshF gene of streptococcus agalactiae and application thereof | |
CN104946552A (en) | Gene engineering strain capable of safely and efficiently producing Phenazino-1-carboxylic acid and application thereof | |
CN105567578A (en) | Ganoderic acid high yield engineering strain kmust-SE | |
CN105602880A (en) | Corynebacterium glutamicum and method for overproduction of phosphatidylserine by means of corynebacterium glutamicum | |
CN103233032A (en) | Corynebacterium glutmicum synthase gene cloning and L183Q site directed mutagenesis method | |
KR100701319B1 (en) | Escherichia coli capable of producing lycopene with enhanced productivity and method for producing lycopene using the same | |
CN105296368A (en) | Recombinant mortierella alpina strain for heterologous expression of MpFADS6 gene, construction method of recombinant mortierella alpina strain and application of recombinant mortierella alpina strain in production of EPA | |
CN111549045B (en) | Vitamin K improvement by utilizing recombinant bacillus natto 2 Method for producing yield | |
CN105368727A (en) | Glucose-6-phosphate dehydrogenase and malic enzyme coordinate-expressed recombinant mortierella alpine strain, constructing method thereof and application thereof | |
CN110564630A (en) | aspergillus ochraceus mutant strain with ochratoxin A gene knockout function and construction and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130410 Termination date: 20150701 |
|
EXPY | Termination of patent right or utility model |